Wouldn’t be at all surprised if TRIP shareholders vote against the merger, look at what has happened to their share price. Looks like CPH is in a terminal spiral, no wonder AB has moved to London. I would guess his name is now on the nose with Australian investors.
Creso Pharma (ASX:CPH) completes Halucenex acquisition, page-18
Add to My Watchlist
What is My Watchlist?